Rosacea Clinic and Classification

  • Gerd Plewig
  • Bodo Melnik
  • WenChieh Chen


Rosacea is a chronic disorder affecting the central parts of the face, characterized by frequent flushing, persistent erythema, and telangiectasia and interspersed with episodes of inflammation during which swelling, papules and pustules, and rarely nodules are evident. The word rosacea is derived from the Latin adjective meaning like roses. The terms acne rosacea and adult acne are misleading and obsolete. Acne and rosacea are separate processes, even though they may sometimes coexist.


  1. Asai Y, Tan J, Baibergenova A, et al. Canadian clinical practice guidelines for rosacea. J Cutan Med Surg. 2016;20:432–45.PubMedGoogle Scholar
  2. Awais M, Anwar MI, Iftikhar R, et al. Rosacea—the ophthalmic perspective. Cutan Ocul Toxicol. 2015;34:161–6.PubMedGoogle Scholar
  3. Baroni A, Russo T, Faccenda F, Piccolo V. Idiopathic facial aseptic granuloma in a child: a possible expression of childhood rosacea. Pediatr Dermatol. 2013;30:394–5.PubMedGoogle Scholar
  4. Barzilai A, Feuerman H, Quaglino P, et al. Cutaneous B-cell neoplasms mimicking granulomatous rosacea or rhinophyma. Arch Dermatol. 2012;148:824–31.PubMedGoogle Scholar
  5. Bettoli V, Mantovani L, Boccia S, Virgili A. Rosacea fulminans related to pegylated interferon alpha-2b and ribavirin therapy. Acta Derm Venereol. 2006;86:258–9.PubMedGoogle Scholar
  6. Bonnar E, Eustace P, Powell FC. The Demodex mite population in rosacea. J Am Acad Dermatol. 1993;28:443–8.PubMedGoogle Scholar
  7. Brubaker DB, Hellstrom RH. Carcinoma occurring in rhinophyma. Arch Dermatol. 1977;113:847–8.PubMedGoogle Scholar
  8. Cabral F, Lubbe LC, Nóbrega MM, et al. Morbihan disease: a therapeutic challenge. An Bras Dermatol. 2017;92:847–50.PubMedPubMedCentralGoogle Scholar
  9. Chamaillard M, Mortemousque B, Boralevi F, et al. Cutaneous and ocular signs of childhood rosacea. Arch Dermatol. 2008;144:167–71.PubMedGoogle Scholar
  10. Chen DM, Crosby DL. Periorbital edema as an initial presentation of rosacea. J Am Acad Dermatol. 1997;37:346–8.PubMedGoogle Scholar
  11. Chen W, Plewig G. Human demodicosis: revisit and a proposed classification. Br J Dermatol. 2014;170:1219–25.Google Scholar
  12. Clark DP, Hanke CW. Electrosurgical treatment of rhinophyma. J Am Acad Dermatol. 1990;22(5 Pt 1):831–7.PubMedGoogle Scholar
  13. Conlledo R, Guglielmetti A, Sobarzo M, et al. Lewandowsky’s rosaceiform eruption: a form of cutaneous tuberculosis confirmed by PCR in two patients. Dermatol Ther (Heidelb). 2014;5:67–76.Google Scholar
  14. Cuétara MS, Aguilar A, Martin L, et al. Erlotinib associated with rosacea-like folliculitis and Malassezia sympodialis. Br J Dermatol. 2006;155:477–9.PubMedGoogle Scholar
  15. Cunliffe WJ, Dodman B, Binner JG. Clonidine and facial flushing in rosacea. Br Med J. 1977;1:105.PubMedPubMedCentralGoogle Scholar
  16. de Morais e Silva FA, Bonassi M, Steiner D, da Cunha TV. Rosacea fulminans in der Schwangerschaft mit okulärer perforation. J Dtsch Dermatol Ges. 2011;9:542–3.PubMedGoogle Scholar
  17. Del Rosso JQ, Tanghetti EA, Baldwin HE, et al. The burden of illness of erythematotelangiectatic rosacea and papulopustular rosacea: findings from a web-based survey. J Clin Aesthet Dermatol. 2017;10:17–31.PubMedPubMedCentralGoogle Scholar
  18. Dev T, Thami T, Longchar M, Sethuraman G. Lupus miliaris disseminatus faciei: a distinctive facial granulomatous eruption. BMJ Case Rep. 2017;2017. pii: bcr-2017-221118.Google Scholar
  19. Dlova NC, Mosam A. Rosacea in black South Africans with skin phototypes V and VI. Clin Exp Dermatol. 2017;42:670–3.PubMedGoogle Scholar
  20. Drolet B, Paller AS. Childhood rosacea. Pediatr Dermatol. 1992;9:22–6.PubMedGoogle Scholar
  21. Dupont C. How common is extrafacial rosacea? J Am Acad Dermatol. 1986;14:839.PubMedGoogle Scholar
  22. Erzurum SA, Feder RS, Greenwald MJ. Acne rosacea with keratitis in childhood. Arch Ophthalmol. 1993;111:228–30.PubMedGoogle Scholar
  23. Forton F, Seys B. Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol. 1993;128:650–9.PubMedGoogle Scholar
  24. Fujiwara S, Okubo Y, Irisawa R, Tsuboi R. Rosaceiform dermatitis associated with topical tacrolimus treatment. J Am Acad Dermatol. 2010;62:1050–2.PubMedGoogle Scholar
  25. Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78:148–55.Google Scholar
  26. Georgouras K, Kocsard E. Micropapular sarcoidal facial eruption in a child: Gianotti-type perioral dermatitis. Acta Derm Venereol. 1978;58:433–6.PubMedGoogle Scholar
  27. Gianotti F, Ermacora E, Bennelli MG, Caputo R. Particulière dermatite péri-orale infantile. Observations sur 5 cas. Bull Soc Fr Dermatol Syphiligr. 1970;77:341.Google Scholar
  28. Goel NS, Burkhart CN, Morrell DS. Pediatric periorificial dermatitis: clinical course and treatment outcomes in 222 patients. Pediatr Dermatol. 2015;32:333–6.PubMedGoogle Scholar
  29. Gudmundsen KJ, O’Donnell BF, Powell FC. Schirmer testing for dry eyes in patients with rosacea. J Am Acad Dermatol. 1992;26:211–4.PubMedGoogle Scholar
  30. Harper J, Del Rosso JQ, Ferrusi IL. Cross-sectional survey of the burden of illness of rosacea by erythema severity. J Drugs Dermatol. 2018;17:150–8.PubMedGoogle Scholar
  31. Harvey DT, Fenske NA, Glass LF. Rosaceous lymphedema: a rare variant of a common disorder. Cutis. 1998;61:321–4.PubMedGoogle Scholar
  32. Helm KF, Menz J, Gibson LE, Dicken CH. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol. 1991;25:1038–43.PubMedGoogle Scholar
  33. Hu L, Alexander C, Velez NF, et al. Severe tacrolimus-induced granulomatous rosacea recalcitrant to oral tetracyclines. J Drugs Dermatol. 2015;14:628–30.PubMedGoogle Scholar
  34. Jansen T, Plewig G. An historical note on pyoderma faciale. Br J Dermatol. 1993;129:594–6.PubMedGoogle Scholar
  35. Jansen T, Plewig G. The treatment of rosaceous lymphedema. Clin Exp Dermatol. 1997;22:57.PubMedGoogle Scholar
  36. Jansen T, Plewig G. Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities. Facial Plast Surg. 1998;14:241–53.PubMedGoogle Scholar
  37. Jansen T, Plewig G, Kligman AM. Diagnosis and treatment of rosacea fulminans. Dermatology. 1993;188:193–6.Google Scholar
  38. Jansen T, Romiti R, Kreuter A, Altmeyer P. Rosacea fulminans triggered by high-dose vitamins B6 and B12. J Eur Acad Dermatol Venereol. 2001;15:484–5.PubMedGoogle Scholar
  39. Jansen T, Melnik BC, Schadendorf D. Steroid-induced periorificial dermatitis in children—clinical features and response to azelaic acid. Pediatr Dermatol. 2010;27:137–42.PubMedGoogle Scholar
  40. Kellen R, Silverberg NB. Pediatric periorificial dermatitis. Cutis. 2017;100:385–8.PubMedGoogle Scholar
  41. Kikuchi I, Saita B, Inoue S. Haber’s syndrome. Report of a new family. Arch Dermatol. 1981;117:321–4.PubMedGoogle Scholar
  42. Kim TG, Noh SM, Do JE, et al. Rosacea fulminans with ocular involvement. Br J Dermatol. 2010;163:877–9.PubMedGoogle Scholar
  43. Kligman AM. Ocular rosacea: current concepts and therapy. Arch Dermatol. 1997;133:89–90.PubMedGoogle Scholar
  44. Lazzeri D, Agostini T, Pantaloni M, Spinelli G. Rhinophyma and non-melanoma skin cancer: an update. Ann Chir Plast Esthet. 2012;57:183–4.PubMedGoogle Scholar
  45. Lee WJ, Jung JM, Won KH, et al. Clinical evaluation of 368 patients with nasal rosacea: subtype classification and grading of nasal rosacea. Dermatology. 2015;230:177–83.PubMedGoogle Scholar
  46. Lee WJ, Jung JM, Lee YJ, et al. Histopathological analysis of 226 patients with rosacea according to rosacea subtype and severity. Am J Dermatopathol. 2016;38:347–52.PubMedGoogle Scholar
  47. Lehmann P. Klinik und Klassifikation der Rosazea. Hautarzt. 2013;64:489–93.PubMedGoogle Scholar
  48. Lewandowsky F. Die Tuberkulose der Haut (plate IV). Berlin: Springer; 1916.Google Scholar
  49. Lewandowsky F. Über rosaceaähnliche Tuberkulide des Gesichtes. Correpondenz-Blatt für Schweizer Ärzte. 1917;47:1280–2.Google Scholar
  50. Leyden JJ, Thew AM, Kligman AM. Steroid rosacea. Arch Dermatol. 1974;110:619–22.PubMedGoogle Scholar
  51. Lloyd KM. Surgical correction of rhinophyma. Arch Dermatol. 1990;126:721–3.PubMedGoogle Scholar
  52. Mattessich S, Ferenczi K, Shahriari M. Persistent malar erythema with atrophy in a young woman. JAMA Dermatol. 2018;154:1215–16.PubMedGoogle Scholar
  53. Machalińska A, Zakrzewska A, Markowska A, et al. Morphological and functional evaluation of meibomian gland dysfunction in rosacea patients. Curr Eye Res. 2016;41:1029–34.PubMedGoogle Scholar
  54. Markou AG, Alessandrini V, Muray JM, et al. Rosacea fulminans during pregnancy. Clin Exp Obstet Gynecol. 2017;44:157–9.PubMedGoogle Scholar
  55. Marks R, Wilson Jones E. Disseminated rosacea. Br J Dermatol. 1969;81:16–28.PubMedGoogle Scholar
  56. Massa MC, Su WP. Pyoderma faciale: a clinical study of twenty-nine patients. J Am Acad Dermatol. 1982;6:84–91.PubMedGoogle Scholar
  57. McCormack CJ, Cowen P. Haber’s syndrome. Australas J Dermatol. 1997;38:82–4.PubMedGoogle Scholar
  58. Mullanax MG, Kierland RR. Granulomatous rosacea. Arch Dermatol. 1970;101:206–11.PubMedGoogle Scholar
  59. Murad A, Fortune A, O’Keane C, Ralph N. Granulomatous rosacea-like facial eruption in an elderly man: leukaemia cutis. BMJ Case Rep. 2016;2016. pii: bcr2016215568.Google Scholar
  60. Nishizawa A, Nakano H, Satoh T, et al. Haber’s syndrome may be a clinical entity different from Dowling-Degos disease. Br J Dermatol. 2009;160:215–7.PubMedGoogle Scholar
  61. O’Leary PA, Kierland RR. Pyoderma faciale. Arch Dermatol Syph. 1940;41:451–62.Google Scholar
  62. Oussedik E, Bourcier M, Tan J. Psychosocial burden and other impacts of rosacea on patients’ quality of life. Dermatol Clin. 2018;36:103–13.PubMedGoogle Scholar
  63. Ozek D, Evren Kemer Ö, Artüz F. Assessment of tear functions in patients with acne rosacea without meibomian gland dysfunction. Ocul Immunol Inflamm. 2018;13:1–4.Google Scholar
  64. Palamar M, Degirmenci C, Ertam I, Yagci A. Evaluation of dry eye and meibomian gland dysfunction with meibography in patients with rosacea. Cornea. 2015;34:497–9.PubMedGoogle Scholar
  65. Plewig G, Kligman AM. Gram-negative rosacea. In: Acne and Rosacea. Berlin, Heidelberg: Springer; 1993. p. 437 and 460.Google Scholar
  66. Plewig G, Jansen T, Kligman AM. Pyoderma faciale. A review and report of 20 additional cases: is it rosacea? Arch Dermatol. 1992;128:1611–7.PubMedGoogle Scholar
  67. Prey S, Ezzedine K, Mazereeuw-Hautier J, et al. IFAG and childhood rosacea: a possible link? Pediatr Dermatol. 2013;30:429–32.PubMedGoogle Scholar
  68. Quarterman MJ, Johnson DW, Abele DC, et al. Ocular rosacea: signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol. 1997;133:49–54.PubMedGoogle Scholar
  69. Ramelet AA. Rosacea: a reactive pattern associated with ocular lesions and migraine? Arch Dermatol. 1994;130:1448.PubMedGoogle Scholar
  70. Reinholz M, Ruzicka T, Steinhoff M, et al. Pathogenesis and clinical presentation of rosacea as a key for a symptom-oriented therapy. J Dtsch Dermatol Ges. 2016;14 Suppl 6:4–15.PubMedGoogle Scholar
  71. Rocas D, Kanitakis J. Lulus miliaris disseminatus faciei: report of a case and brief literature review. Dermatol Online J. 2013;19:4.PubMedGoogle Scholar
  72. Sanderson KV, Wilson HT. Haber’s syndrome. Familial rosacea-like eruption with intraepidermal epithelioma. Br J Dermatol. 1965;77:1–8.PubMedGoogle Scholar
  73. Schüürmann M, Wetzig T, Wickenhauser C, et al. Histopathology of rhinophyma—a clinical-histopathologic correlation. J Cutan Pathol. 2015;42:527–35.PubMedGoogle Scholar
  74. Skowron F, Causeret AS, Pabion C, et al. F.I.GU.R.E.: facial idiopathic granulomas with regressive evolution. is “lupus miliaris disseminatus faciei” still an acceptable diagnosis in the third millenium? Dermatology. 2000;201:287–9.PubMedGoogle Scholar
  75. Sobye P. Aetiology and pathogenesis of rosacea. Acta Derm Venereol (Stockh). 1950;30:137–40.Google Scholar
  76. Spoendlin J, Voegel JJ, Jick SS, Meier CR. Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom. J Am Acad Dermatol. 2013;69:399–406.PubMedGoogle Scholar
  77. Steinhoff M, Schmelz M, Schauber J. Facial erythema of rosacea—aetiology, different pathophysiologies and treatment options. Acta Derm Venereol. 2016;96:579–86.Google Scholar
  78. Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176:431–8.PubMedGoogle Scholar
  79. Tan J, Berg M, Gallo RL, et al. Applying the phenotype approach for rosacea to practice and research. Br J Dermatol. 2018;179:741–6.PubMedGoogle Scholar
  80. Tempark T, Shwayder TA. Perioral dermatitis: a review of the condition with special attention to treatment options. Am J Clin Dermatol. 2014;15:101–13.PubMedGoogle Scholar
  81. Teraki Y, Hitomi K, Sato Y, Izaki S. Tacrolimus-induced rosacea-like dermatitis: a clinical analysis of 16 cases associated with tacrolimus ointment application. Dermatology. 2012;224:309–14.Google Scholar
  82. Toda-Brito H, Aranha JMP, Tavares ES. Lupus miliaris disseminatus faciei. An Bras Dermatol. 2017;92:851–3.PubMedPubMedCentralGoogle Scholar
  83. Tüzün Y, Wolf R, Kutlubay Z, et al. Rosacea and rhinophyma. Clin Dermatol. 2014;32:35–46.PubMedGoogle Scholar
  84. Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72:749–58.PubMedGoogle Scholar
  85. van Zuuren EJ. Rosacea. N Engl J Med. 2017;377:1754–64.PubMedPubMedCentralGoogle Scholar
  86. Vanstreels L, Megahed M. Lupoide Rosazea als Sonderform der Rosazea. Einblick in die Pathogenese und Therapieoptionen. Hautarzt. 2013;64:886–8.PubMedGoogle Scholar
  87. Walsh RK, Endicott AA, Shinkai K. Diagnosis and treatment of rosacea fulminans: a comprehensive review. Am J Clin Dermatol. 2018;19:79–86.PubMedGoogle Scholar
  88. Webster G, Schaller M. Ocular rosacea: a dermatologic perspective. J Am Acad Dermatol. 2013;69(6 Suppl 1):S42–3.PubMedGoogle Scholar
  89. Williams HC, Ashworth J, Pembroke AC, Breathnach SM. FACE—facial Afro-Caribbean childhood eruption. Clin Exp Dermatol. 1990;15:163–6.PubMedGoogle Scholar
  90. Xie HF, Huang YX, He L, et al. An observational descriptive survey of rosacea in the Chinese population: clinical features based on the affected locations. Peer J. 2017;5:e3527.PubMedGoogle Scholar
  91. Zeichner JA, Eichenfield LF, Feldman SR, et al. Quality of life in individuals with erythematotelangiectatic and papulopustular rosacea: findings from a web-based survey. J Clin Aesthet Dermatol. 2018;11:47–52.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Gerd Plewig
    • 1
  • Bodo Melnik
    • 2
  • WenChieh Chen
    • 3
  1. 1.Department of Dermatology and AllergyLudwig-Maximilian-University MunichMunichGermany
  2. 2.Department of Dermatology, Environmental Medicine and Health TheoryUniversity of OsnabrückOsnabrückGermany
  3. 3.Department of Dermatology and AllergyTechnical University of MunichMunichGermany

Personalised recommendations